Clinical trial design

#Clinical trial design #Clinical trials #Drug development #Drug discovery

Is disclosure non-compliance harming drug development?

Ali Pashazadeh, Founder and CEO of Treehill Partners, explores how clinical trial disclosure non-compliance is placing major pressures on clinical development, biopharma investment, and patient access to life saving therapies. Clinical trial disclosure non-compliance is rarely discussed and often ignored as a problem in the drug development sector. It is,… Read More

#Exclusive Content

#Clinical trial design #Clinical trials #Phase I trial #Phase II trial

New DDW Highlights vodcast: 15 July 2024

Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format.   Clinical trial news has caught… Read More

#News

#Clinical trial design #Clinical trials #Phase I trial #Phase II trial

New DDW Highlights podcast: 15 July 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Clinical trial news has caught our attention this week. Despite the revelation… Read More

#News

#Clinical trial design #Clinical trials #Phase I trial #Phase II trial

This week in drug discovery (8-12 July) 

News round-up for 8-12 July by DDW Senior Digital Content Editor Diana Spencer. Clinical trial news has caught our attention this week. Despite the revelation from Phesi that a third of clinical trials fail at Phase II, DDW has reported positive human trial updates on therapeutics for myasthenia… Read More

#News

Clinical trial
#Cannabinoid #Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials #Medicinal cannabis #Plant-based

New podcast: How to utilise clinical trials in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers three articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Medicinal cannabis: Why more clinical… Read More

#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Phesi

AI digital twins could replace control arm in clinical trials

A new study demonstrates that AI-powered digital twin solutions can potentially replace the standard-of-care (SOC) control arm of a clinical trial. The paper was co-authored by analytics company Phesi and Dr Yi-Bin Chen, Director for the Blood and Marrow Transplant Program at Massachusetts General Hospital. Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Machine learning #PhaseV

ML could facilitate increased adoption of adaptive clinical trials

A new machine learning (ML) software platform has been launched to facilitate wider adoption of advanced and adaptive clinical trials. The latest version of AdaptV includes an advanced mode to support more in-depth modifications of relevant algorithmic and statistical parameters that go into trial design, accounting… Read More

#News

Brain Awareness Week
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical trial design #Machine learning

How large language models can elevate clinical research

Deepika Khedekar investigates the use of LLMs in clinical trials and how we can overcome the potential challenges to their wider application. $2.3 billion1 is the estimated cost of bringing a new drug from the drawing board to pharmacy shelves today. Clinical trials make up a… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

#Artificial intelligence (AI) #Cancer research #Clinical trial design #Oncology

From data to cure: The journey of AI in cancer trials

Deepika Khedekar, Associate Centralized Clinical Trial Lead at IQVIA Inc, looks at the challenges of utilising artificial intelligence (AI) in oncology clinical research. Ten million1 people around the world die from cancer each year. Yet, while the number of cancer clinical trials has soared from 19,211… Read More

#Cancer Research #Exclusive Content

Diversity
#Clinical trial design #Clinical trials #Diversity #University of Oxford

Deterrents to trial participation among ethnic minorities revealed

Safety and health concerns, time investment, and lack of support are the top three barriers to participation in clinical studies among ethnic minorities, according to a new report. The study examined the motivators and deterrents of clinical trial participation among ethnic minorities and outlined strategies sponsors can utilise… Read More

#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Machine learning

AI and machine learning: A new era for clinical trials

Fiona Maini, Senior Director Global Compliance & Strategy, at Medidata looks at the rise of artificial intelligence (AI) and machine learning (ML) within life sciences and the applications for the technology in clinical trials. The benefits that AI and machine learning (ML) can bring to society and their potential to… Read More

#Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Clinical trial design #Collaboration #Exonate #Exploristics #Ophthalmology

Partners enhance trial design using cloud-based simulation

Exploristics and Exonate have announced the completion of a successful collaboration to optimise the study design for Exonate’s upcoming Phase IIb study for diabetic eye disease. The collaboration has supported ongoing development of Exonate’s lead candidate, EXN407, following a recent successful Phase Ib/IIa study in November. Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Data security #Decentralised clinical trials

Decentralised identities: Blockchain based informed consent

Industry experts explain how blockchain can fundamentally enhance clinical trials. Obtaining consent from patients or healthy volunteers is a fundamental requirement for enrolling participants on to clinical trials. Methods for obtaining consent use paper-based Informed Consent Forms (ICFs) must be signed on site by the participant in the presence… Read More

#Exclusive Content

#Clinical trial design #Dementia #Funding #Neurodegenerative disorders #University College London

UK dementia research gets £49.9 million funding boost

Head of clinical trials at the University College London (UCL) Dementia Research Centre, Dr Cath Mummery, has been announced as the Director of a new network of dementia trial sites across the country. The UK government has authorised £49.9 ($63.4) million of new funding to improve… Read More

#Editor's Choice #News

Patient using a mammography machine
#Breast cancer #Cancer research #Clinical trial design #Clinical trials #Oncology #Phase II trial #Phesi

Breast cancer most researched disease area for third year running

Breast cancer was the most studied disease in 2023 for the third consecutive year, followed by solid tumours, stroke, Covid-19 and prostate cancer. The analysis of 65,749 recruiting clinical trials was conducted by data analytics company Phesi, as part of an annual global analysis of clinical… Read More

#Cancer Research #News #Trending News